A synthetic heptapeptide analogue of ACTH(4-10), registered as a prescription drug in Russia for ischemic stroke and optic nerve conditions. One of the most frequently discussed "nootropic peptides" in biohacking communities, alongside Selank.
Cognitive / nootropic · Neuroprotection
A mixture of low-molecular-weight peptides and amino acids derived from purified porcine brain proteins, approved in several countries for stroke and traumatic brain injury recovery. Distinct from single-sequence research peptides—it's a multi-component biological preparation.
Cognitive / nootropic · Neuroprotection
An 11-amino-acid peptide engineered from a non-erythropoietic region of erythropoietin, designed to activate tissue-repair signaling without stimulating red blood cell production. Studied in phase 2 human trials for small-fiber neuropathy—one of the more clinically tested "tissue protective" peptides.
Recovery · Neuroprotection
Evidence labels
- EmergingMostly preclinical or early signals; human athletic data is thin.
- Limited human dataSome human pharmacology or small studies; outcomes for fitness use remain limited.
- Stronger clinical signalSupported by larger clinical trials in defined medical populations.
Same color code everywhere on STACKD: green = stronger clinical/human data, amber = limited human data or mechanism, slate = emerging/anecdotal, and oxblood = an in-house STACKD summary.